PDI was originally identified as a disulfide isomerase containing two thioredoxin domains that catalyze the formation, breakage, and rearrangement of disulfide bonds, thus radio/chemo-resistance in PDI-overexpression cancer cells was considered to correlate with its enzyme activity [50]. The gene discussed is TXNDC15; the disease is cancer.